INSIGHT-Drug makers, scientists begin the hunt for long COVID treatments
Leading drug makers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease, five scientists in the United States and UK told Reuters.
Companies including GlaxoSmithKline GSK.L, Vir Biotechnology VIR.O and Humanigen HGEN.O
confirmed they had spoken to researchers on trials using their current treatments against long COVID.
Others including Pfizer PFE.N and Roche ROG.S said they are interested but would not elaborate on plans.
Big pharmaceutical companies are looking for disease-specific biomarkers that would allow them to assess the value of tested medicines, experts say.
disease-specific biomarkers
All the big boys are out there looking that's for sure
https://www.nasdaq.com/articles/ins...ists-begin-the-hunt-for-long-covid-treatments
Will the news drop today
see how we go
Chart, page-5634
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.004(6.25%) |
Mkt cap ! $61.30M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 7.1¢ | 6.5¢ | $198.2K | 2.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14845 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
0.004 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 6.6¢ | 7.1¢ | 6.6¢ | 295714 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PER (ASX) Chart |